$UNH

UNITEDHEALTH GROUP INC

1
10
2

No SEC Form 4 filings for $UNH in the last 30 days.

See all $UNH insider activity →
Low

ETFs Are Net Sellers of UnitedHealth (UNH) on Sept. 24

On Sept. 24, ETFs were net sellers of UnitedHealth (UNH) shares, with $55.1 million sold. This follows two days of net buying. SPY and DIA were among the largest sellers. UNH has a market cap of $338.0 billion and a YTD return of 16.34%.

UnitedHealthcare Is Dropping Prior Authorization for Roughly 1,700 Medical Procedures in October. Only About 120 Apply to Medicare Advantage, Where It Denied 17% of Standard Requests

UnitedHealthcare will drop prior authorization for 1,700 medical procedures in October, but only 120 apply to Medicare Advantage plans. UnitedHealth Group (UNH) reported a 17% denial rate for Medicare Advantage prior authorization requests in 2025, the highest among large insurers. The company aims to reduce prior authorization volume by 30% by year-end and process 80% in real time by 2027.

Does New CAO Role Change The Bull Case For UnitedHealth Group (UNH)?

UnitedHealth Group (UNH) appointed Jodee Kozlak as its first chief administrative officer, effective September 28, 2026. Kozlak will oversee People, Real Estate, Procurement, and Corporate Security to support modernization. Analysts discuss how this role may impact UNH's efficiency and governance, with key focus on managing cost pressures and operational scrutiny. UNH's investment narrative centers on Medicare mix issues, controlling medical costs, and platform efficiency.

UNH sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 13 news stories mentioning UNH (UNITEDHEALTH GROUP INC). Coverage has skewed bearish: 1 bullish, 10 neutral, and 2 bearish.

Recent UNH coverage spans financial news, regulation and corporate actions.

What's driving UNH

AlphAI scores every news story that mentions UNH with an AI model for sentiment and relevance, and aggregates insider trades from UNITEDHEALTH GROUP INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $UNH

Score
$UNHLow

UnitedHealthcare Is Dropping Prior Authorization for Roughly 1,700 Medical Procedures in October. Only About 120 Apply to Medicare Advantage, Where It Denied 17% of Standard Requests

UnitedHealthcare will drop prior authorization for 1,700 medical procedures in October, but only 120 apply to Medicare Advantage plans. UnitedHealth Group (UNH) reported a 17% denial rate for Medicare Advantage prior authorization requests in 2025, the highest among large insurers. The company aims to reduce prior authorization volume by 30% by year-end and process 80% in real time by 2027.

$UNHLow

Does New CAO Role Change The Bull Case For UnitedHealth Group (UNH)?

UnitedHealth Group (UNH) appointed Jodee Kozlak as its first chief administrative officer, effective September 28, 2026. Kozlak will oversee People, Real Estate, Procurement, and Corporate Security to support modernization. Analysts discuss how this role may impact UNH's efficiency and governance, with key focus on managing cost pressures and operational scrutiny. UNH's investment narrative centers on Medicare mix issues, controlling medical costs, and platform efficiency.

$UNHLow

UnitedHealth executive acquires 53 dividend shares

UnitedHealth Group Inc. EVP & Chief People Officer Erin McSweeney acquired 53 dividend-equivalent shares on September 22, 2026, tied to outstanding restricted stock units. The shares are forfeited if the units do not vest. McSweeney's direct holdings increased to 15,654 shares. The transaction price was $0.00 per share.

Cantor Fitzgerald reiterates UnitedHealth stock rating on pricing outlook

Cantor Fitzgerald reiterated an Overweight rating and $495 price target for UnitedHealth Group (UNH), citing undervaluation and improving 2027 margin outlook. The firm's survey indicates UNH priced independent dispute resolution later than peers, with blended risk pricing up 180 basis points to 10.5% in 2027. UNH stock has returned 38% over the past six months, with recent earnings beats and raised price targets from other analysts.

$LLYMed

Florida Sues Eli Lilly, Novo Nordisk and Pharmacy Benefit

Florida sued Eli Lilly, Novo Nordisk, and pharmacy benefit managers, alleging they used rebates to maintain high drug prices, harming patients and independent pharmacies. The state claims these practices discouraged competition and limited access to affordable treatments, seeking damages and changes to pricing practices. The case focuses on insulin and GLP-1 medications, with Florida citing significant market power among the defendants.

Related tickers